問卷

TPIDB > Principal Investigator

Principal Investigator


Taipei Chang Gung Medical Foundation

Division of Dermatology

更新時間:2025-12-01

鄭椿昱
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2025-11-03 - 2027-12-31

Phase III

Active
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of OBI- 858 in Subjects with Moderate to Severe Glabellar Lines.
  • Condition/Disease

    Moderate to severe frown lines

  • Test Drug

    Freeze-dried injection

Participate Sites
8Sites

Recruiting8Sites